Shunmei’s Shun Tranpass Guidewire: Precision-Driven Neurovascular Medical Devices
Providing physicians with tools that enhance control and confidence during delicate neurovascular procedures is our mission at Shunmei Medical Co., Ltd. With three state-of-the-art production bases in Huizhou, Hunan, and Turkey, and distribution in over 120 countries, Shunmei is well-known worldwide for its commitment to creating neurovascular medical devices that are tailored to meet the needs of actual clinical settings.
Shun Tranpass 200/300: Control and Visibility in Neurovascular Navigation
The Neural Micro Guidewire – Shun Tranpass 200/300 represents a refined approach to neurovascular access and support. Developed to provide exceptional torque control and enhanced flexibility, this neurovascular medical device offers the precise handling required for complex navigation in the brain's intricate vascular structure. Its engineering focuses on reliability without compromising responsiveness, which is essential during critical interventions.
Engineered for Visual Clarity and Intravascular Feedback
One standout feature of the Shun Tranpass 200/300 is its 10 cm platinum-nickel alloy coil tip, designed for fluoroscopic visibility. This allows clinicians to track the guidewire's exact position throughout the procedure with ease. Unlike many neurovascular medical devices that require trade-offs between flexibility and radiopacity, our guidewire delivers both. It offers dependable visual feedback under imaging, helping medical teams make confident, real-time decisions during navigation and device deployment.
Balancing Stability and Flexibility in Every Procedure
Stability and flexibility often pull in opposite directions in micro guidewire design. Shunmei engineers have overcome this challenge by combining advanced material selection with refined structural tuning. The Shun Tranpass 200/300 provides just enough pushability for smooth vessel entry while maintaining the pliability necessary to track tortuous neurovascular paths. This balanced performance is key for procedures involving aneurysms, ischemic stroke access, and other delicate neurovascular targets.
Global Collaboration for Targeted Neurovascular Solutions
With a presence in over 120 countries and support from our three wholly-owned subsidiaries, Shunmei builds neurovascular medical devices that reflect the needs of global medical communities. We work alongside interventional neurologists and neurosurgeons to ensure that each neurovascular medical device addresses practical clinical challenges while meeting strict international quality standards.
Conclusion
Every tool we create is designed with the patient outcome in mind. At Shunmei, we are not just producing devices—we are supporting life-saving interventions. Our commitment to refining neurovascular medical devices like the Shun Tranpass 200/300 positions us as a dependable partner in high-stakes environments. As neurovascular procedures continue to evolve, we remain focused on providing solutions that support accuracy, safety, and control.
